Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

82

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

GPR17 – orphan G protein-coupled receptor with therapeutic potential

GPR17 – orphan G protein-coupled receptor with therapeu...

142

Campylobacter jejuni-derived cytolethal distending toxin promotes colorectal cancer metastasis

Campylobacter jejuni-derived cytolethal distending toxi...

81

ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains

ATXN3 regulates lysosome regeneration after damage by t...

81